Bacterial bloodstream infections in the allogeneic hematopoietic cell transplant patient: new considerations for a persistent nemesis - Takeaways - MDSpire

Bacterial bloodstream infections in the allogeneic hematopoietic cell transplant patient: new considerations for a persistent nemesis

  • By

  • C E Dandoy

  • M I Ardura

  • G A Papanicolaou

  • J J Auletta

  • March 27, 2017

  • 0 min

Share

  • 1

    Allogeneic hematopoietic cell transplantation (allo-HCT) is crucial for treating various malignancies and immune deficiencies.

  • 2

    Bacterial bloodstream infections (BSIs) are a leading cause of morbidity and mortality in allo-HCT patients.

  • 3

    Central line-associated bloodstream infections (CLABSIs) have the highest incidence in the allo-HCT population compared to other high-risk groups.

  • 4

    Pre-engraftment BSIs are primarily linked to neutropenia, central venous catheters, and severe mucositis.

  • 5

    Post-engraftment BSIs are associated with acute or chronic graft-versus-host disease and result in poorer patient outcomes.

Original Source(s)

Bacterial bloodstream infections in the allogeneic hematopoietic cell transplant patient: new considerations for a persistent nemesis

  • by C E Dandoy, M I Ardura, G A Papanicolaou, J J Auletta

  • March 27, 2017

Related Content

Case Report and Epidemiological Investigation of Healthcare-associated Plasmodium falciparum Malaria Transmission in Westchester County, New York—2023

The 46th Annual Meeting of the European Society for Blood and Marrow Transplantation: Quality Management Group Poster Session (P722-P740)

  • December 11, 2020

Blood and marrow transplantation during the emerging COVID-19 pandemic: the Seattle approach